CFO
RMD icon

CVA Family Office’s ResMed RMD Stock Holding History

CVA Family Office’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.9K Sell
174
-72
-29% -$14.9K ﹤0.01% 688
2026
Q1 		$55.2K Buy
246
+63
+34% +$15.7K 0.01% 573
2025
Q4 		$44.1K Sell
183
-32
-15% -$8.18K 0.01% 567
2025
Q3 		$58.9K Buy
215
+14
+7% +$3.82K 0.01% 520
2025
Q2 		$51.9K Sell
201
-8
-4% -$1.91K 0.01% 541
2025
Q1 		$46.8K Buy
209
+48
+30% +$11.2K 0.01% 534
2024
Q4 		$36.8K Buy
161
+28
+21% +$6.74K 0.01% 576
2024
Q3 		$32.5K Buy
133
+20
+18% +$4.47K 0.01% 580
2024
Q2 		$21.6K Hold
113
– – ﹤0.01% 627
2024
Q1 		$22.4K Buy
113
+3
+3% +$550 ﹤0.01% 624
2023
Q4 		$18.9K Buy
+110
New +$16.9K ﹤0.01% 635
2023
Q3 		– Sell
-155
Closed -$33.9K – 790
2023
Q2 		$33.9K Buy
155
+40
+35% +$8.91K 0.01% 522
2023
Q1 		$25.2K Sell
115
-5
-4% -$1.08K 0.01% 552
2022
Q4 		$25K Sell
120
-90
-43% -$19.8K 0.01% 525
2022
Q3 		$46K Buy
210
+130
+163% +$29.6K 0.01% 391
2022
Q2 		$17K Sell
80
-70
-47% -$14.9K ﹤0.01% 568
2022
Q1 		$36K Buy
150
+30
+25% +$7.26K 0.01% 461
2021
Q4 		$31K Buy
+120
New +$31.1K 0.01% 449
2021
Q3 		– Sell
-120
Closed -$30K – 777
2021
Q2 		$30K Buy
120
+50
+71% +$10.5K 0.01% 440
2021
Q1 		$14K Buy
+70
New +$14K 0.01% 481

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

CVA Family Office's RMD Position: Q2 2026 in Review

CVA Family Office reduced its ResMed (RMD) stake by 29% in Q2 2026, selling an estimated $14.9K and leaving 174 shares worth $33.9K. The position accounts for ﹤0.01% of the portfolio, ranked #688.

CVA Family Office first reported a position in RMD in Q1 2021 and has held it in 20 quarters since. The position peaked at $58.9K in Q3 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • CVA Family Office held 174 shares of ResMed worth $33.9K as of Q2 2026.
  • CVA Family Office sold 72 ResMed shares in Q2 2026, an estimated $14.9K.
  • ResMed made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #688 holding.
  • CVA Family Office first reported a position in ResMed in Q1 2021 and has held it in 20 quarters since.
  • CVA Family Office's ResMed position peaked at $58.9K in Q3 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.